Warf 2 mg
Available Dosages
| SKU | 1199 |
|---|---|
| Generic For | Coumadin |
| Strength | 2 mg |
| Manufacturer | Unisearch |
| Active Ingredient | Warfarin |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.09 | US$ 2.59 | |||
|
|||||
| 60 Tablet/s | US$ 0.09 | US$ 5.19 | |||
|
|||||
| 90 Tablet/s | US$ 0.09 | US$ 7.79 | |||
|
|||||
Warf 2 mg (Warfarin) – Affordable Coumadin Alternative
Warf 1 mg contains Warfarin to prevent harmful blood clots from forming, moving to other areas of the body or growing larger. These blood clots can block blood flow, potentially causing serious conditions such as strokes, heart attacks, pulmonary embolism, or deep vein thrombosis. As Warfarin tends to interfere with the formation of blood clots, it is often referred to as an anticoagulant. These medications are also called blood thinners; however, the medicine does not cause blood thinning but instead causes the blood to take longer to form a clot.
The formation of a blood clot is part of a complex process that involves the role of clotting factors. Administration of Warfarin reduces the body’s ability to form blood clots by inhibiting the formation of vitamin K-dependent clotting factors, which play a crucial role in blood clotting and preventing bleeding. By using Warf 2 mg, a medication that blocks the activity of clotting factors, your body prevents the formation of blood clots and stops existing ones from growing larger.
Warf 2 mg is not recommended in pregnant women. Females who become pregnant or plan to become pregnant while taking this medicine should immediately notify their healthcare specialist.
If you are undergoing surgery or a dental procedure, you may need to discontinue treatment. People who take Warf 2 mg should consult their healthcare provider before taking any new medicine, including over-the-counter medicines, vitamins, and herbal products. Many medications can interact with the effectiveness of Warfarin 2 mg. Some common over-the-counter pain relievers, including naproxen and ibuprofen, increase the anticoagulant effects of Warfarin and increase the risk of harmful bleeding.
Alcohol: Alcohol can affect the metabolism of Warfarin in the body. While undergoing anticoagulation, avoid alcohol consumption or limit the consumption (drink in moderation). Talk to your healthcare specialist if you are receiving Warfarin and drink alcohol. Excessive consumption may increase the risk of developing major bleeding, and it can also decrease the effect of your anticoagulant drug.
Foods: Certain foods can interfere with the effectiveness of this medicine. Generally, there is no need to make any significant changes to the diet. Your healthcare professional will tell you if any dietary restrictions need to be followed.
Vitamin K: A diet rich in vitamin K can make the anticoagulant treatment less effective and increase the risk of developing blood clots. You may not need to avoid these foods completely, but it is essential to maintain a consistent intake of vitamin K.
Interactions: A variety of drug interactions can result in the reduction of Warfarin's anticoagulant properties. Some interacting medicines result in unpredictable effects. Possible drug interactions include anabolic steroids, aspirin, cimetidine, disulfiram, amiodarone, other NSAIDs, sulphinpyrazone, sulphonamides, clofibrate, phenylbutazone, sulphonylurea type antidiabetic medicines, thyroid hormone and many more. Consult your healthcare provider for a complete list of potential drug interactions.
Side effects of Warfarin tablet
Warfarin is essential for your health, but like any other pharmaceutical agent, it, too, can cause serious and life-threatening bleeding problems. Serious side effects include:
- Purple toe syndrome: Seek immediate medical attention if you develop pain in your toes and they appear purple or dark in colour.
- Death of skin tissue: This can occur soon after treatment initiation. It occurs because blood clots form, restricting blood flow to a specific area of your body. Seek immediate medical help if you experience pain, fever, or changes in colour in any area of your body. Immediate medical care is necessary to prevent death or loss of the affected body part.
Headache is commonly reported with the use of Warfarin 2 mg; however, if it becomes severe, it could indicate a brain bleed or haemorrhage.
Excessive bleeding may occur in any part of the body, and patients taking Warfarin should report the signs of bleeding. Signs of bleeding include:
- Bleeding into a joint
- Bleeding from the gums
- Vomiting blood
- Blood in the urine
- A nosebleed
- Bloody or black stool
Other side effects associated with the use of Warfarin include allergic reactions, low blood pressure, paleness, low red blood cells, rash and fever. Consult your healthcare professional if you experience any adverse reactions that become troublesome or persistent.
The treatment goal is to decrease the tendency to form blood clots rather than prevent clotting completely. The treatment must be closely monitored with the assistance of regular blood tests. The daily dose of the anticoagulant medicine will be adjusted based on the results of the blood tests. Your healthcare specialist is the best source of information for questions and concerns related to medical issues. Do not stop the treatment unless you experience severe bleeding or are advised by your healthcare professional. Avoid making any changes unless any dietary restrictions are recommended.
What is Warf 2mg used for?
Warf 2mg contains warfarin Sodiumium 2mg — a commonly used warfarin tablet strength for anticoagulation. Warfarin 2mg tablets are used as the primary dose unit in many patients, as a maintenance dose building block, and for alternate-day dosing regimens (e.g. alternating 2mg and 3mg daily for a 2.5mg average). Key indications are the same as all warfarin preparations: atrial fibrillation stroke prevention, VTE treatment and prevention, mechanical heart valve anticoagulation, and antiphospholipid syndrome. Warf 2mg provides a practical middle-strength option between the 1mg and 5mg tablets.
How is the Warf 2mg dose determined for individual patients?
Warfarin dosing is individualised by INR target and patient factors. Genetic testing (CYP2C9 and VKORC1 variants) can predict dose requirements before initiation — CYP2C9 poor metabolisers and VKORC1 AA genotype patients need significantly lower doses. Standard clinical approach: start at 5–10mg, check INR at 48–72 hours, adjust based on INR response. Most patients stabilise between 3–9mg/day. A patient requiring 2mg/day uses Warf 2mg as a single daily tablet. A patient requiring 2.5mg alternates 2mg and 3mg tablets on alternate days. Consistent INR monitoring with dose adjustments guided by pharmacist or anticoagulation clinic is essential.
How often should INR be checked on Warf 2mg therapy?
INR frequency: initiation phase — daily or every 2 days until two consecutive INRs within target range; 1–2 weeks of stable INR — weekly checks; 4+ weeks of stable INR — monthly checks; stable long-term patients — every 6–8 weeks at most. If any dose change is made — recheck INR in 5–7 days. If a new medication is started — recheck INR within 5–7 days. If dietary changes occur (illness, travel, dietary restriction) — unscheduled INR. Point-of-care INR testing (CoaguChek, INRatio) allows home monitoring for motivated patients, improving stability and convenience.
What is the 'sick day' management rule for Warf 2mg?
Illness can significantly destabilise warfarin control: reduced eating (less dietary vitamin K — INR rises), vomiting/diarrhoea (poor absorption, dehydration), fever (increases warfarin metabolism rate changes), and new medications for illness (many common medications interact). During illness: check INR within 1–2 days if unwell, particularly with fever, poor oral intake, or new medications (including antibiotics, paracetamol, NSAIDs). Paracetamol (acetaminophen) in doses above 2g/day regularly significantly increases INR — a commonly overlooked interaction. Notify anticoagulation clinic of any illness and new medication for INR management guidance.
Is Warf 2mg safe in patients with liver disease?
Warfarin is particularly risky in liver disease — the liver produces clotting factors (II, VII, IX, X), and liver disease alone impairs coagulation. Baseline INR is already elevated in significant liver disease, making warfarin monitoring unreliable. In mild liver disease (Child-Pugh A), warfarin can be used with frequent monitoring and lower target INR. In moderate-to-severe liver disease (Child-Pugh B or C), warfarin is very high risk and generally avoided — direct oral anticoagulants or specialist haematology guidance are required. Portal vein thrombosis in cirrhotic patients: specialist-guided anticoagulation with direct oral anticoagulants or low-molecular-weight heparin is increasingly preferred.
What surgery precautions apply to patients on Warf 2mg?
Peri-operative warfarin management: minor procedures (dental extractions, skin biopsy, cataract surgery): often safe to continue warfarin with INR checked on the day — local haemostatic measures are adequate. Major surgery: warfarin is typically stopped 5 days before; check INR 1–2 days pre-operatively (target <1.5 before surgery). Bridging therapy with low molecular weight heparin (LMWH) may be needed for high-thrombotic-risk patients (mechanical heart valves, recent VTE, high-risk AF) — specialist anticoagulation or haematology advice. Restart warfarin 12–24 hours post-surgery when bleeding risk is acceptable; concurrent LMWH until INR reaches target again.
How does Warf 2mg compare to rivaroxaban for atrial fibrillation?
Warfarin 2mg (adjusted for target INR 2–3) and rivaroxaban 20mg once daily both prevent AF-related stroke. Rivaroxaban advantages: fixed dose, no INR monitoring, fewer drug-food interactions, rapid onset/offset, and similar/superior stroke prevention in trials (ROCKET-AF). Warfarin advantages: reversible with vitamin K, lower cost, multiple strength options, and established data in mechanical valve patients (rivaroxaban is contraindicated). In CHA₂DS₂-VASc score-guided AF treatment, DOACs like rivaroxaban are preferred over warfarin in most new patients without contraindications.
Is Warf 2mg equivalent to Coumadin 2mg?
Yes. Warf 2mg and branded Coumadin 2mg both contain warfarin Sodiumium 2mg in bioequivalent formulations. Warf is the generic version — when switching between warfarin products, INR should be checked within 1–2 weeks to confirm stability, as minor formulation variations occasionally affect INR.
Can I order Warf 2mg from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Warf 2mg to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified anticoagulants, competitive pricing, and free worldwide shipping on qualifying orders make us a trusted international pharmacy for warfarin therapy.
What patient education is most important for Warf 2mg therapy?
Essential warfarin education: (1) Never miss an INR appointment — anticoagulation monitoring is non-negotiable; (2) Carry an anticoagulation alert card or MedicAlert bracelet at all times; (3) Maintain consistent dietary patterns — don't suddenly start or stop eating leafy greens; (4) Check with pharmacist/doctor before any new medication, supplement, or herbal remedy; (5) Know bleeding warning signs (see above) and have an emergency plan; (6) Take warfarin at the same time daily; (7) Do not adjust your own dose without professional advice; (8) Inform all healthcare providers (surgeon, dentist, A&E) that you take warfarin.
What is time in therapeutic range (TTR) and why does it matter for Warf 2mg?
Time in therapeutic range (TTR) measures the percentage of time a patient's INR is within their target range (typically 2–3). Higher TTR equals better outcomes — both stroke prevention AND reduced bleeding. A TTR >70% is the benchmark for well-controlled warfarin — this is the standard patients achieve with good anticoagulation management. TTR below 65% indicates inadequately controlled warfarin — consider switch to a DOAC. Factors reducing TTR: poor adherence, frequent diet changes, drug interactions, illness, and infrequent INR monitoring. Anticoagulation clinic management consistently achieves better TTR than GP-only management due to specialist guidance and dosing algorithms.
Login
Sign Up
Login
Sign Up